Filing Details
- Accession Number:
- 0000899243-22-020666
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-02 16:05:41
- Reporting Period:
- 2022-06-01
- Accepted Time:
- 2022-06-02 16:05:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1724979 | Rain Therapeutics Inc. | RAIN | Pharmaceutical Preparations (2834) | 821130967 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1856682 | Avanish Vellanki | C/O Rain Therapeutics Inc. 8000 Jarvis Avenue, Suite 204 Newark CA 94560 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-01 | 25,000 | $2.29 | 2,471,627 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $2.285 to $2.3268. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.